Italian study evaluates COVID-19 reinfection risk among previously infected and vaccinated individuals

..

Excerpts:

*Important notice

Research Square publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

By Dr. Chinta Sidharthan Oct 31 2022
Reviewed by Aimee Molineux

In a recent study posted to the Research Square* preprint server, a team of researchers from Italy investigated the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection and hospitalization among individuals with vaccinations and previous SARS-CoV-2 infections.
.

About the study

The present research performed two case-control studies among COVID-19 patients registered at the Local Health Unit (LHU) in Vercelli, Italy, to estimate the efficacy of vaccination- and previous SARS-CoV-2 infection-induced immunity against infections and hospitalizations. The researchers also evaluated the effect of the SARS-CoV-2 Omicron variant on hybrid immunity and analyzed the efficacy of booster doses. The role of chronicity in SARS-CoV-2 infection and hospitalization risks was also assessed.

The analyzed data comprised demographic information on the patients registered at the LHU, swab-testing information, the dates and doses of vaccination administrations, hospital admission and discharge dates, the International Classification of Diseases, 9th revision (ICD-9-CM) code, drug provision information, and prescription charge exemptions for chronic diseases.
.

Results

The results indicated that when vaccinations and previous infections were evaluated independently, vaccination reduced the risk of infections by 36% and the risk of hospitalization by 89%. Prior SARS-CoV-2 infections reduced reinfection and hospitalization risks by 65% and 90%, respectively. Vaccinated individuals with previous SARS-CoV-2 infections were at 62% and 98% lower risk of reinfections and hospitalizations, respectively.
.

The Omicron variants had a significant effect in reducing the immunity induced by vaccinations and previous infections. After the emergence of the Omicron variant, the risk of disease among vaccinated individuals went from 43% to 67%. Unvaccinated, previously infected individuals exhibited a 45% reduction in reinfection risk after the Omicron variant’s emergence, compared to the 89% risk reduction seen before Omicron became prevalent. Individuals with vaccinations and previous infections also showed a decrease in protective effects against SARS-CoV-2 after the emergence of the Omicron variant (60% as compared to 79% before Omicron prevalence).

Conclusions

Overall, the results indicated hybrid immunity from completed primary vaccinations and previous SARS-CoV-2 infections significantly reduced reinfection and severity risks, even in individuals with chronic underlying health conditions.

The immune evasion by the Omicron variant resulted in a reduction in the protective effects of vaccination and previous infections. The efficacy of booster doses in increasing protection against infections and severe COVID-19 needs to be examined.

*Important notice

Research Square publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.
Research Square publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Written by
Chinta Sidharthan is a writer based in Bangalore, India. Her academic background is in evolutionary biology and genetics, and she has extensive experience in scientific research, teaching, science writing, and herpetology. Chinta holds a Ph.D. in evolutionary biology from the Indian Institute of Science and is passionate about science education, writing, animals, wildlife, and conservation. For her doctoral research, she explored the origins and diversification of blindsnakes in India, as a part of which she did extensive fieldwork in the jungles of southern India. She has received the Canadian Governor General’s bronze medal and Bangalore University gold medal for academic excellence and published her research in high-impact journals.

https://www.news-medical.net/news/20221031/Italian-study-evaluates-COVID-19-reinfection-risk-among-previously-infected-and-vaccinated-individuals.aspx

..

Posted in Uncategorized | Tagged | Leave a comment

Johor Baru: Teenager beaten up by 10 men after meeting a foreign woman he had met online

..

It was at about 5am.

..

..

..

Posted in Uncategorized | Tagged | Leave a comment

Dark Side of Hong Kong: The Real Life Dystopia

..

..

Posted in Uncategorized | Tagged | Leave a comment

China continues to build state-run canteens

..

..

.

.

Posted in Uncategorized | Tagged , | Leave a comment

Who Will Win GE15? Ft. Tony Pua

..

..

Posted in Uncategorized | Tagged | Leave a comment

Singapore launches programme to prepare for the next infectious disease outbreak | THE BIG STORY

..

..

Posted in Uncategorized | Leave a comment

We are UMNO: When we disagree, we fight

..

..

..

..

..

Posted in Uncategorized | Tagged | Leave a comment

Vote for the P.M. you want

..

https://smartpolls.co.uk/p/5939

https://smartpolls.co.uk/p/5939

..

Posted in Uncategorized | Leave a comment

Assassination attempt: Former Pakistan Prime Minister Imran Khan shot during protest march

..

..

..

..

..

..

..

Posted in Uncategorized | Tagged | Leave a comment

New analysis on the risk for myocarditis or pericarditis after mRNA COVID-19 vaccination

..

New analysis on the risk for myocarditis or pericarditis after mRNA COVID-19 vaccination

Reviewed by Emily Henderson, B.Sc. Nov 1 2022

A comprehensive review and meta-analysis of published research confirm that young adults (40 years old and younger) have a slightly elevated risk for myocarditis or pericarditis after mRNA COVID-19 vaccination. The analysis is reported in a new study in the American Journal of Preventive Medicine, published by Elsevier.

Our study analyzes data to identify who might be at high risk for myocarditis/pericarditis after COVID-19 vaccination and validates the rare adverse reaction in adults under 40.”

Chenyu Sun, MD, MSc, Lead Investigator, AMITA Health Saint Joseph Hospital Chicago, Chicago, IL, USA

Key findings include:

  • A second vaccine dose is associated with a greater risk of the cardiovascular reaction than the first dose.
  • The increased risk is only associated with mRNA (e.g., mRNA-1273 and BNT162b2 – the latter linked to a slightly lower risk than the former), but not other vaccine types (e.g., Corona-Vac.).
  • While males are more likely to develop myocarditis/pericarditis (established by research prior to the pandemic), female susceptibility increases after the COVID-19 vaccine.
  • The incidence of myocarditis/pericarditis for those infected with SARS-CoV-2 is higher than it is after vaccination.

.
Dr. Sun pointed out, “When myocarditis or pericarditis develop after a COVID-19 vaccination, the symptoms are usually less severe and largely self-remitting compared with other cases. As a clinician, I strongly recommend that people get a COVID 19 vaccine unless there are absolute contraindications such as known allergies. The benefits and harms must be carefully assessed to determine the best management option for patients who are in the high risk-group.”
.

The comprehensive literature search identified 1,123 relevant published papers. Of these the investigators selected 11 studies on COVID-19 vaccination and the risk of myocarditis or pericarditis that met their rigorous criteria; eight of them compared the incidence of myocarditis or pericarditis before and after COVID-19 vaccination and three analyzed the effect of different doses of vaccination on the incidence of myocarditis or pericarditis. Based on data on more than 58 million participants in these studies, the investigators analyzed the effects of different sexes, ages, regions, vaccination types, and doses on the risk of myocarditis or pericarditis.
.

Source:

Elsevier

Journal reference:

Gao, J., et al. (2022) A Systematic Review and Meta-analysis of the Association Between SARS-CoV-2 Vaccination and Myocarditis or Pericarditis. American Journal of Preventive Medicine. doi.org/10.1016/j.amepre.2022.09.002.

https://www.news-medical.net/news/20221101/New-analysis-on-the-risk-for-myocarditis-or-pericarditis-after-mRNA-COVID-19-vaccination.aspx

..

Posted in Uncategorized | Tagged | Leave a comment